跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AMOXICILLIN/CLAV - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AMOXICILLIN/CLAV
Authorized
STANDARD
AMOXICILLIN/CLAV
sanis health inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
409a31823ea4bac6
Company
sanis health inc
Type
Standard
Approval Details
Approval Id
409a31823ea4bac6
Drug Approval Canada Name
AMOXICILLIN/CLAV
Product Name
AMOXICILLIN/CLAV
Status
Marketed
Status Date
2024-02-20
Original Market Date
2024-02-20
Din
02536048
Drug Class
Human
Dosage Form
Tablet
Route Of Administration
Oral
Schedule
Prescription
Ahfs
08:12.16.08
Atc Original
J01CR02 AMOXICILLIN AND BETA-LACTAMASE INHIBITOR
Atc Name
j 01 cr 02
Aig Number
0234720005
Company Name
sanis health inc
Company Address
1 Presidents Choice Circle, Brampton, Ontario, Canada, L6Y 5S5
Active Ingredients
AMOXICILLIN (AMOXICILLIN TRIHYDRATE)
875 MG
CLAVULANIC ACID (CLAVULANATE POTASSIUM)
125 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
409a31823ea4bac6
Type
Standard
Back to Health Canada Approvals